Form 4: DENTSPLY SIRONA Director Betsy Holden Increases Stake Through RSU Dividends

DENTSPLY SIRONA Inc. Director Betsy D. Holden acquired 502.594 shares of common stock through dividends on restricted stock units, increasing her total beneficial ownership to 53,255.959 shares.

Summary

• Betsy D. Holden, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 502.594 shares of common stock on July 11, 2025.
• This acquisition represents dividends on previously awarded restricted stock units (RSUs), issued in the form of additional RSUs.
• The newly acquired RSU dividends are subject to the same vesting terms as the underlying awards and vest simultaneously with them.
• Each RSU converts to common stock on a 1:1 basis.
• Following this transaction, Betsy D. Holden directly beneficially owns a total of 53,255.959 shares of DENTSPLY SIRONA Inc. common stock.
• A Limited Power of Attorney, executed on May 22, 2025, authorizes Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Section 16 reports on behalf of Betsy D. Holden.

Sentiment

Score: 7

Explanation: The filing indicates a routine insider transaction (acquisition of shares via RSU dividends) which is generally positive as it increases director ownership and aligns interests, but it does not convey significant new strategic or financial news.

Positives

• Director Betsy D. Holden increased her beneficial ownership in DENTSPLY SIRONA Inc. by 502.594 shares through RSU dividends.
• The acquisition of shares via RSU dividends indicates ongoing compensation and aligns the director's interests with those of shareholders.

Risks

• The acquired restricted stock units (RSUs) are subject to vesting terms, meaning the shares are not fully owned until those conditions are met.

Future Outlook

The acquired restricted stock units (RSUs) are subject to future vesting terms, indicating that the full beneficial ownership of these specific shares is contingent upon meeting those conditions.

Management Comments

• The transaction reflects the company's compensation structure for directors, including the issuance of restricted stock units and dividends thereon.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across publicly traded companies, reflecting standard director compensation practices involving equity awards like Restricted Stock Units (RSUs) and their associated dividends. It does not provide broader industry trends.

Comparison to Industry Standards

• The issuance of restricted stock units (RSUs) and their dividends as part of director compensation is a common practice among publicly traded companies, aligning director interests with shareholder value.
• While specific comparable companies or projects are not detailed in this filing, this compensation mechanism is widely adopted across various industries, including healthcare and dental technology, similar to practices at companies like Align Technology (ALGN) or Henry Schein (HSIC) which also utilize equity-based compensation for their executives and directors.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased director ownership aligns interests with shareholders, potentially signaling confidence in the company's long-term prospects.

Next Steps

• The acquired restricted stock units (RSUs) will vest according to their predetermined schedule, at which point they will convert to common stock.

Key Dates

Recommendation

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Restricted Stock Units, RSU Dividends, Director Compensation, Share Ownership, SEC Filing